Should the chickenpox vaccine be included in the National Immunization Schedule in India?

Hum Vaccin. 2011 Aug;7(8):874-7. doi: 10.4161/hv.7.8.15685. Epub 2011 Aug 1.

Abstract

Varicella (chickenpox) is an acute, highly contagious viral disease with worldwide distribution. The highest prevalence occurs in the 4-10 year age group but tends to be more severe in adults. It may be fatal in neonates, immunocompromised persons, and normal adults, especially smokers. Varicella is usually a benign childhood disease, and rarely rated as an important public health problem, but this can be severe and even fatal in otherwise healthy children (< 1 out of every 10,000 cases). Chickenpox can cause pneumonia (23 out of every 10,000 cases), and is an important risk factor for developing severe invasive "strep" (group A streptococcal disease). Complications of varicella include bacterial infections (up to 5% of cases), decreased platelets, arthritis, hepatitis, pneumonia (more commonly in adults) or encephalitis (1 in 10,000 cases), which may cause a failure of muscular coordination, sometimes resulting in persistent sequelae or death. Varicella is the leading cause of vaccine-preventable death in children. Universal vaccination can cause a dramatic reduction in the incidence of varicella, associated complications, hospitalizations and fatality rates. In India, due to the high cost of the vaccine, it would be difficult to vaccinate a large percentage of the children. The government of India should consider the inclusion of varicella vaccine in the National Immunization Schedule with the help of International agencies.

MeSH terms

  • Adult
  • Chickenpox / epidemiology
  • Chickenpox / immunology
  • Chickenpox / prevention & control*
  • Chickenpox Vaccine / administration & dosage*
  • Chickenpox Vaccine / immunology
  • Child
  • Humans
  • Immunization Programs*
  • Immunization Schedule
  • India / epidemiology
  • Infant
  • Infant, Newborn
  • Mass Vaccination*
  • Public Health

Substances

  • Chickenpox Vaccine